Skip to content

MAZE MAZE Free cash flow

Free cash flow at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.29B+66.4%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$26.47M-11.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$60.94M-146%
Zymeworks logo
ZymeworksZYME
-$45.93M-1,242%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$72.96M-13.0%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$51.2M

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Calculated from MAZE’s reported figures.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's free cash flow?
MAZE (MAZE) reported free cash flow of -$39.21M in Q1 2026.
How has MAZE's free cash flow changed year-over-year?
MAZE's free cash flow decreased by 31.5% year-over-year, from -$29.82M to -$39.21M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.